我們中的許多人在櫃子裡有我們不再需要的舊處方藥物，或是舊的過期的非處方藥物。服用過期的藥物並不安全，儲存不需要的藥物會增加孩子進入藥物並被中毒的風險。其他藥物有時會被濫用，這些藥物可能是被濫用藥物風險的青少年服用。為了幫助人們安全處置藥物，禁毒管理局（DEA）將於 10 月 26 舉行全國處方藥物回收日。全國處方藥回收日搜索您附近的收集站點。未使用的處方藥可以在收集地點安全和匿名處置。
儘管最好通過處方藥物取回計劃擺脫舊藥物，但如果需要，則可以其他方式處置它們。美國食品藥品監督管理局有關如何安全丟棄舊藥物的指示，並提供了他們建議沖洗的藥物清單。「沖洗清單」中的藥物特別危險，因為它們很容易過量，而有些藥物經常被濫用。如果您有「沖洗清單」中的其中一種藥物，並且不再需要藥物，最好將其立即丟棄，而不是等待藥物取回事件，以立即清除藥物。
我們中的許多人在櫃子裡有我們不再需要的舊處方藥物，或是舊的過期的非處方藥物。服用過期的藥物並不安全，儲存不需要的藥物會增加孩子進入藥物並被中毒的風險。其他藥物有時會被濫用，這些藥物可能是被濫用藥物風險的青少年服用。為了幫助人們安全處置藥物，禁毒管理局（DEA）將於 10 月 28 舉行全國處方藥物回收日。全國處方藥回收日搜索您附近的收集站點。
儘管最好通過處方藥物取回計劃擺脫舊藥物，但如果需要，則可以其他方式處置它們。美國食品藥品監督管理局有關如何安全丟棄舊藥物的指示，並提供了他們建議沖洗的藥物清單。「沖洗清單」中的藥物特別危險，因為它們很容易過量，而有些藥物經常被濫用。如果您有「沖洗清單」中的其中一種藥物，並且不再需要藥物，最好將其立即丟棄，而不是等待藥物取回事件，以立即清除藥物。
Kratom (Mitragyna speciosa) is a tropical tree native to Southeast Asia. When the leaves are consumed it produces stimulant effects in low doses, and sedative effects in high doses. Some people take kratom, against warnings, to reduce opioid cravings or treat pain. Others take it recreationally, believing it helps improve their mood.
Kratom contains a variety of chemicals. The two major psychoactive ingredients are mitragynine and 7-hydroxymytragynine (7-OH). Kratom is mostly abused by ingesting it in the form of a tablet, capsule, or extract. Some individuals ingest it as a tea or simply chew the leaf. Laboratory-synthesized 7-OH is being sold and added to kratom products exposing users to concentrations of psychoactive ingredients that are unexpected and harmful.
Kratom was first introduced into the US in the late 1990s and for years its use was very limited. In recent years kratom use has become much more common, possibly because of the opioid epidemic and people trying to use kratom to reduce their dependence on opioids. Kratom is easily available and often sold in gas stations, smoke/vape shops, corner stores, and online. According to an analysis of 2015-2025 data from the National Poison Data System (NPDS), the U.S. Centers for Disease Control and Prevention (CDC) found that kratom-related exposures reported to NPDS increased by approximately 1,200%, reaching record levels in 2025.
A 2019 study on Poison Control Center calls related to kratom found they’ve become much more common in the past few years. In 2011 Poison Control Centers received 13 calls about kratom. This rose to 682 in 2017, and two-thirds of the 1807 kratom-related calls between 2011–2017 happened in 2016 and 2017.
The Food and Drug Administration (FDA) has warned people not to take kratom because of safety concerns and the risk of addiction. The sale of kratom is not approved by the FDA meaning the FDA has not:
Since kratom is not approved by the FDA; different products can differ in strength and could have unknown contaminants. Companies selling kratom don’t have to follow safe manufacturing regulations, and in 2018 there was an outbreak caused by Salmonella bacteria in kratom that made people sick in 41 states.
People can overdose on kratom, and it can interact with other medications, alcohol, or recreational drugs in ways that can be dangerous. Kratom has been linked to drug-associated deaths. In most cases kratom was taken along with other drugs, but in a few cases, kratom was the only drug used. Kratom can be addictive, and babies born to mothers who use kratom sometimes have to be treated for opioid withdrawal symptoms.
Some states or localities have laws against the sale or possession of kratom. In Virginia, it is illegal to sell kratom to people under the age of 21. As of November 2026, kratom products must include a label listing all the ingredients and a warning about potential dependency and opioid-like withdrawal. The law also bans the sale of products containing 7-OH.
There are currently no federal laws regulating kratom, although the FDA has used its authority to regulate unapproved drugs and unapproved dietary additives to restrict the import of kratom. In July 2026, the U.S. Drug Enforcement Administration (DEA) filed its intent to temporarily place 7-OH into Schedule 1 of the Controlled Substances Act (CSA).
Kratom is a drug and can have side effects that can be dangerous. Stimulant side-effects occur at low doses while sedative side-effects occur at higher doses. Kratom causes loss of appetite, anorexia, insomnia, tremors, hallucinations, confusion, and rapid heartbeat. People often report feeling itchy after taking it. It can cause nausea and vomiting. At high doses kratom can cause seizures. People who take kratom regularly can develop liver injury.
Tell your doctor. Even if you don’t plan to stop taking kratom you should talk to your doctor about potential interactions with other medications or drugs or alcohol and the possibility of becoming dependent on kratom. Women who are pregnant, planning to become pregnant, or nursing should stop taking kratom to protect their baby from exposure. Like drugs, kratom should be stored out of the reach of children.
如果您或其他人（尤其是兒童）誤食了卡痛，請撥打毒物管制中心熱線 1-800-222-1222。如果患者出現嚴重的副作用，請撥打 911。
已更新：2026
美國禁毒管制局今天發布公共安全警報，關於與木拉辛混合苯甲酸的販運量增加。木拉辛是一種用於鎮靜馬的獸藥，並未經批准用於人類。在過去的幾年裡，木拉辛已開始作為許多街頭藥物中的添加劑。被發現與芬坦尼爾，海洛因，可卡因和其他藥物混合。它有時單獨以「Tranq」出售。
服用 xylazine 的人可能會昏昏沉沉、昏睡過去，也可能會出現低血壓、心跳減緩和呼吸緩慢。 如果服用過量，可能會導致死亡。同時服用 Xylazine 和 fentanyl 尤為危險，因為這兩種藥物都會減緩呼吸，並可能導致呼吸完全停止。使用芬太尼等阿片類藥物過量時，可以使用納洛酮（Narcan）逆轉，但納洛酮對於嗪類藥物過量無效。注射 Xylazine 也會造成皮膚潰瘍。這會造成無法癒合的深瘡，有時甚至需要截肢。
如果您或您認識的人一直在使用木拉辛或其他藥物，則可以致電 SAMHSA 國家幫助熱線 1-800-662-HELP (4357) 以獲取有關藥物濫用的信息和幫助戒煙的資源。您還可以在 FindTreatment.gov 上獲取有關您所在地區的成癮治療計劃的信息。
弗吉尼亞州行為健康部 & 發展服務提供有關藥物濫用的信息，為使用毒品或酒精並可能懷孕或可能懷孕的人提供服務，以及如何使用納洛克遜治療阿片類藥物過量過量的培訓。
弗吉尼亞州社會服務部提供了針對藥物濫用幫助的人，並且使用 Medicaid 或沒有保險的人提供信息。
